Free CME from PeerView


Cardiology CME

Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Critical Conversations on Atrial Fibrillation: A MasterClass Series
April 04, 2023
Credits: 1.0 CME / MOC
Penn State College of Medicine
Loosening the Grip of Hypertrophic Cardiomyopathy: Updated Strategies for Timely Diagnosis and Disease-Modifying Treatment
March 05, 2023
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Medicine in Motion: Visual Guide to a New Generation in Care for Patients With Hypertrophic Cardiomyopathy
March 03, 2023
Credits: 0.5 CME
Penn State College of Medicine
Medicine in Motion: Smarter Approaches for Diagnosing HoFH
March 02, 2023
Credits: 0.5 CME
Penn State College of Medicine
Medicine in Motion: Smart Approaches for Treating HoFH
February 22, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Building a Safety-Centric Culture in B-Cell Cancers: Interprofessional Insights on Optimizing BTKi Efficacy Through Safety Management
January 31, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know
January 22, 2023
Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
December 16, 2022
Credits: 1.0 CME
University of Florida College of Medicine
Personalizing the Management of Hyperlipidemia: Addressing Unmet Needs Among High-Risk Patients With Atherosclerotic Cardiovascular Disease With Novel Lipid-Lowering Therapies
November 07, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: Cardiology-Focused Perspectives on Using SGLT2 Inhibitors to Optimize Outcomes in Patients With Heart Failure
November 06, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Heart Failure Society of America
Pushing Back Against HCM: Can Cardiac Myosin Inhibitors Alter the Disease Progression and Management Trajectory for Patients With Hypertrophic Cardiomyopathy?
October 21, 2022
Credits: 0.5 CME
University of Florida College of Medicine
Envisioning the Future of Hyperlipidemia Management: How Can We Leverage PCSK9-Targeting Therapies to Prevent Primary and Secondary Cardiovascular Events?
September 29, 2022
University of Florida College of Medicine
New Therapies, New Hope: Evolving Strategies for Improving Outcomes and Quality of Life in Patients With Hypertrophic Cardiomyopathy
May 12, 2022
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
May 06, 2022
PVI, PeerView Institute for Medical Education
New Evidence on Cardiac Myosin Inhibition in Hypertrophic Cardiomyopathy: Analysis From Washington, DC
April 20, 2022
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
March 31, 2022
Medical Learning Institute, Inc.
Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
February 11, 2022
PVI, PeerView Institute for Medical Education
Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science, and Strategies for Early Diagnosis and Tailored Treatment
November 13, 2021
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
October 04, 2021

Pages